An open-label, non-randomized, single-arm, Expanded Access
Program (EAP) trial conducted to explore potential signals of
efficacy of COVID-19 convalescent plasma.
Read more here: inpharmd.com/covid
About the Podcast
We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.